STOCK TITAN

Danaher to Present at TD Cowen Health Care Conference

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags

Danaher (NYSE: DHR) announced that President and CEO Rainer M. Blair will present at the TD Cowen Healthcare Conference in Boston on March 3, 2025 at 1:50 p.m. ET. The presentation will be webcast and accessible via Danaher's Investors site under Events & Presentations.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

Conference date: March 3, 2025 Presentation time: 1:50 p.m. ET
2 metrics
Conference date March 3, 2025 TD Cowen Healthcare Conference presentation date
Presentation time 1:50 p.m. ET Scheduled time for Danaher CEO’s conference presentation

Market Reality Check

Price: $210.92 Vol: Volume 2,280,730 is 0.46x...
low vol
$210.92 Last Close
Volume Volume 2,280,730 is 0.46x the 20-day average of 4,947,903, indicating subdued trading ahead of this conference update. low
Technical Shares at 210.92 are trading slightly above the 200-day MA of 209.65, indicating a stable, mildly constructive trend pre-conference.

Peers on Argus

DHR gained 0.68% while key peers like TMO, A, LH, and MTD also showed gains and ...

DHR gained 0.68% while key peers like TMO, A, LH, and MTD also showed gains and IDXX declined. However, no peers appeared in the momentum scanner, so the move screens as stock-specific rather than a broad sector rotation.

Common Catalyst Conference participation appears as a shared theme, with both DHR and TMO announcing healthcare conference presentations.

Historical Context

5 past events · Latest: Feb 17 (Positive)
Pattern 5 events
Date Event Sentiment Move Catalyst
Feb 17 Masimo acquisition terms Positive -2.9% Announced cash acquisition of Masimo for $180 per share, totaling $9.9B.
Feb 17 Masimo deal metrics Positive -2.9% Detailed Masimo EBITDA, synergy targets, and expected EPS accretion from the acquisition.
Jan 28 Q4 and FY2025 earnings Positive -4.8% Reported revenue and EPS growth, strong cash flow, and introduced FY2026 guidance range.
Jan 12 Q4 outlook commentary Positive +0.3% CEO previewed Q4 revenue and EPS near high end of prior guidance.
Jan 05 J.P. Morgan presentation Neutral +0.5% Announced CEO presentation and webcast access at J.P. Morgan Healthcare Conference.
Pattern Detected

Recent history shows several fundamentally positive events (acquisitions, earnings growth) followed by negative price reactions, while routine conference-related updates have coincided with modest gains.

Recent Company History

Over the past few months, Danaher has reported solid Q4 and FY2025 results with revenue and EPS growth, issued FY2026 guidance, and announced the Masimo acquisition for about $9.9 billion. Despite these strategic and financial positives, shares fell after the earnings and Masimo deal headlines. By contrast, prior announcements about management presentations at healthcare conferences saw small positive moves, similar in nature to today’s TD Cowen conference update.

Market Pulse Summary

This announcement highlights an upcoming TD Cowen Healthcare Conference presentation by Danaher’s CE...
Analysis

This announcement highlights an upcoming TD Cowen Healthcare Conference presentation by Danaher’s CEO on March 3, 2025, with a webcast available to investors. It follows recent earnings, guidance, and a major acquisition announcement that shaped the company’s trajectory. Investors may focus on any incremental commentary around integration of recent deals, demand trends, and the outlook versus prior guidance, as management often uses conference platforms to refine qualitative messaging.

AI-generated analysis. Not financial advice.

WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conference in Boston, Massachusetts on Tuesday, March 3, 2025 at 1:50 p.m. ET. The event will be simultaneously webcast and can be accessed on the "Investors" section of Danaher's website, www.danaher.com, under the subheading "Events & Presentations."

ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 60,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.

Cision View original content:https://www.prnewswire.com/news-releases/danaher-to-present-at-td-cowen-health-care-conference-302696210.html

SOURCE Danaher Corporation

FAQ

When will Danaher (DHR) present at the TD Cowen Healthcare Conference?

Rainer M. Blair will present on March 3, 2025 at 1:50 p.m. ET as scheduled for the conference. According to the company, the presentation is part of the TD Cowen Healthcare Conference in Boston and will be webcast for investors to view online.

Who from Danaher (DHR) is presenting at the March 3, 2025 TD Cowen Healthcare Conference?

Danaher's President and CEO, Rainer M. Blair, is presenting at the conference on March 3, 2025. According to the company, Blair will represent Danaher and the session will be simultaneously webcast and available via the Investors Events & Presentations page.

How can investors watch Danaher's (DHR) TD Cowen presentation on March 3, 2025?

The presentation will be simultaneously webcast and available online for investors to access. According to the company, the webcast can be found on Danaher's website in the Investors section under Events & Presentations.

What time is Danaher's (DHR) presentation scheduled at the TD Cowen Healthcare Conference?

Danaher's presentation is scheduled for 1:50 p.m. ET on March 3, 2025 during the TD Cowen Healthcare Conference. According to the company, the session takes place in Boston and will be broadcast via the company's webcast channel.

Will Danaher's (DHR) TD Cowen presentation be available after the live event?

The presentation will be webcast and is typically archived for later viewing on the company site. According to the company, investors can check the Investors Events & Presentations page for the live webcast and any subsequent replay availability.

Where is the TD Cowen Healthcare Conference taking place for Danaher's (DHR) presentation?

The conference session is in Boston, Massachusetts on March 3, 2025 where Danaher will present live. According to the company, the event will also be simultaneously webcast and available via Danaher's Investors Events & Presentations webpage.
Danaher Corporation

NYSE:DHR

DHR Rankings

DHR Latest News

DHR Latest SEC Filings

DHR Stock Data

148.10B
629.60M
Diagnostics & Research
Industrial Instruments for Measurement, Display, and Control
Link
United States
WASHINGTON